Innovative research team achievement column

Function and mechanism study of hypoxia-induced long non-coding RNA 68 in hepatocellular carcinoma

  • Lu TAN ,
  • Shaoming SHEN ,
  • Ping HE
Expand
  • 1.Department of Pathophysiology, Shanghai Jiao Tong University College of Basic Medical Sciences, Shanghai 200025, China
    2.Institute of Aging and Tissue Repair, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200240, China
    3.Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200240, China
HE Ping, E-mail: phe@shsci.org.

Received date: 2024-02-26

  Accepted date: 2024-03-15

  Online published: 2024-06-28

Supported by

National Natural Science Foundation of China(82103233);Innovative Research Team of High-Level Local Universities in Shanghai(SHSMU-ZDCX20211800)

Abstract

Objective ·To investigate the biological roles and associated mechanisms of the hypoxia-induced long non-coding RNA 68 (HILRNA68) in hepatocellular carcinoma (HCC) cell lines. Methods ·Long non-coding RNA (lncRNA) microarray analysis was conducted to study the differential expression of lncRNAs in the HCC cell lines cultured under hypoxia treatment and normoxia treatment separately for 12 h, and DEseq2 R package was used for the analysis of differentially expressed lncRNAs. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to determine the differential lncRNAs. Short hairpin RNAs (shRNAs) were used to knock down hypoxia-inducible factors (HIFs) to investigate whether HILRNA68 transcription was regulated by HIFs under hypoxia. Nucleus-cytoplasmic isolation combined with qRT-PCR and RNA fluorescence in situ hybridization (RNA-FISH) experiments were used to investigate the subcellular localization of HILRNA68. HILRNA68 was knocked down in SMMC-7721 and MHCC-97H cells by small interfering RNA (siRNA) to investigate its cellular function under hypoxia. The impact of HILRNA68 on the cell proliferation and invasion capabilities of HCC cells under hypoxia was examined by cell counting and Transwell assays. Dual-luciferase reporter assay was employed to identify how HILRNA68 regulated the transcriptional activity of HIFs under hypoxia. Results ·By differential expression analysis of lncRNAs, a total of 247 and 17 significantly (defined as fold change≥4, FDR≤0.05) up- and down-regulated lncRNAs, respectively, were identified. Among these differentially expressed genes, lncRNA HILRNA68 was up-regulated about 10-fold in multiple HCC cell lines when cultured under hypoxia for 12 h. Knockdown of HIF1α, HIF2α, and HIF1β significantly suppressed (all P<0.05) the upregulation of HILRNA68 under hypoxia. Luciferase reporter assay suggested that the transcription of HILRNA68 was regulated by HIFs. Subcellular localization studies revealed that HILRNA68 was mainly localized in the nucleus. Biological function experiments showed that silencing of HILRNA68 significantly inhibited the proliferation and invasion of HCC cells under hypoxia (all P<0.05). Mechanistic studies demonstrated that knock-down of HILRNA68 significantly suppressed the transcriptional activity of HIF1α under hypoxia (P<0.05) and the up-regulation of these canonical HIFs targets under hypoxia was also significantly inhibited after HILRNA68 knockdown (P<0.05). Conclusion ·The current study identifies a series of differential hypoxia-regulated lncRNAs and functionally annotates the upregulated HILRNA68. HILRNA68 is directly up-regulated by HIFs which promotes cell proliferation and invasion under hypoxia. Mechanistically, the upregulation of HILRNA68 under hypoxia enhances the transcriptional activity of HIF1α.

Cite this article

Lu TAN , Shaoming SHEN , Ping HE . Function and mechanism study of hypoxia-induced long non-coding RNA 68 in hepatocellular carcinoma[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024 , 44(6) : 702 -712 . DOI: 10.3969/j.issn.1674-8115.2024.06.005

References

1 VOGEL A, MEYER T, SAPISOCHIN G, et al. Hepatocellular carcinoma[J]. Lancet, 2022, 400(10360): 1345-1362.
2 SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
3 CHIDAMBARANATHAN-REGHUPATY S, FISHER P B, SARKAR D. Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification[J]. Adv Cancer Res, 2021, 149: 1-61.
4 JING X M, YANG F M, SHAO C C, et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment[J]. Mol Cancer, 2019, 18(1): 157.
5 BAO M H R, WONG C C L. Hypoxia, metabolic reprogramming, and drug resistance in liver cancer[J]. Cells, 2021, 10(7): 1715.
6 CHEN Z, HAN F F, DU Y, et al. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions[J]. Signal Transduct Target Ther, 2023, 8(1): 70.
7 INFANTINO V, SANTARSIERO A, CONVERTINI P, et al. Cancer cell metabolism in hypoxia: role of HIF-1 as key regulator and therapeutic target[J]. Int J Mol Sci, 2021, 22(11): 5703.
8 YUEN V W H, WONG C C L. Hypoxia-inducible factors and innate immunity in liver cancer[J]. J Clin Invest, 2020, 130(10): 5052-5062.
9 BHAN A, SOLEIMANI M, MANDAL S S. Long noncoding RNA and cancer: a new paradigm[J]. Cancer Res, 2017, 77(15): 3965-3981.
10 ALI T, GROTE P. Beyond the RNA-dependent function of lncRNA genes[J]. Elife, 2020, 9: e60583.
11 SCHMITZ S U, GROTE P, HERRMANN B G. Mechanisms of long noncoding RNA function in development and disease[J]. Cell Mol Life Sci, 2016, 73(13): 2491-2509.
12 MCCABE E M, RASMUSSEN T P. lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions[J]. Semin Cancer Biol, 2021, 75: 38-48.
13 HUANG Z, ZHOU J K, PENG Y, et al. The role of long noncoding RNAs in hepatocellular carcinoma[J]. Mol Cancer, 2020, 19(1): 77.
14 BOEREN J, GRIBNAU J. Xist-mediated chromatin changes that establish silencing of an entire X chromosome in mammals[J]. Curr Opin Cell Biol, 2021, 70: 44-50.
15 TIRPE A A, GULEI D, CIORTEA S M, et al. Hypoxia: overview on hypoxia-mediated mechanisms with a focus on the role of HIF genes[J]. Int J Mol Sci, 2019, 20(24): 6140.
16 PAREDES F, WILLIAMS H C, SAN MARTIN A. Metabolic adaptation in hypoxia and cancer[J]. Cancer Lett, 2021, 502: 133-142.
17 DZHALILOVA D S, MAKAROVA O V. HIF-dependent mechanisms of relationship between hypoxia tolerance and tumor development[J]. Biochemistry, 2021, 86(10): 1163-1180.
18 TAYLOR C T, SCHOLZ C C. The effect of HIF on metabolism and immunity[J]. Nat Rev Nephrol, 2022, 18(9): 573-587.
19 MANUELLI V, PECORARI C, FILOMENI G, et al. Regulation of redox signaling in HIF-1-dependent tumor angiogenesis[J]. FEBS J, 2022, 289(18): 5413-5425.
20 XUE Y C, CHEN R S, QU L H, et al. Noncoding RNA: from dark matter to bright star[J]. Sci China Life Sci, 2020, 63(4): 463-468.
21 XU F Y, HUANG M Q, CHEN Q Y, et al. LncRNA HIF1A-AS1 promotes gemcitabine resistance of pancreatic cancer by enhancing glycolysis through modulating the AKT/YB1/HIF1α pathway[J]. Cancer Res, 2021, 81(22): 5678-5691.
22 MA C N, WO L L, WANG D F, et al. Hypoxia activated long non-coding RNA HABON regulates the growth and proliferation of hepatocarcinoma cells by binding to and antagonizing HIF-1α[J]. RNA Biol, 2021, 18(11): 1791-1806.
23 YANG K X, ZHANG W Y, ZHONG L H, et al. Long non-coding RNA HIF1A-As2 and MYC form a double-positive feedback loop to promote cell proliferation and metastasis in KRAS-driven non-small cell lung cancer[J]. Cell Death Differ, 2023, 30(6): 1533-1549.
24 ZHENG F, CHEN J N, ZHANG X Q, et al. The HIF-1α antisense long non-coding RNA drives a positive feedback loop of HIF-1α mediated transactivation and glycolysis[J]. Nat Commun, 2021, 12(1): 1341.
25 WANG Y, CHEN W Y, LIAN J Y, et al. The lncRNA PVT1 regulates nasopharyngeal carcinoma cell proliferation via activating the KAT2A acetyltransferase and stabilizing HIF-1α[J]. Cell Death Differ, 2020, 27(2): 695-710.
26 YANG F, ZHANG H F, MEI Y D, et al. Reciprocal regulation of HIF-1α and lincRNA-p21 modulates the Warburg effect[J]. Mol Cell, 2014, 53(1): 88-100.
Outlines

/